Global Assisted reproductive technology Market

Global Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization (IVF), Artificial Insemination (AI-IUI)), By Procedure(Fresh Donor, Fresh Non-donor), By End User(Hospitals, Fertility Clinics) - Industry Forecast 2024-2031


Report ID: SQMIG35G2228 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 91 | Figures: 76

Global Assisted Reproductive Technology Market Insights

Assisted Reproductive Technology Market size was valued at USD 2101.5 million in 2019 and is poised to grow from USD 2507.09 million in 2023 to USD 12272.5 million by 2031, growing at a CAGR of 19.3% in the forecast period (2024-2031).

The treatments used to treat infertility are referred to as assisted reproductive technology, sometimes known as assisted reproductive treatment. Depending on the cause of infertility, these therapies involve a wide range of techniques. In-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo transfer (FET), and gamete intrafallopian transfer are all common treatments for such circumstances (GIFT). Assisted reproductive technologies involve methods that involve both eggs and embryos and do not consist of a pill-only therapy.

Increasing prevalence of infertility due to changing lifestyle, rising stress level among general population, and increased government initiatives to support fertility services are driving demand for assisted reproductive technology. Furthermore, the emergence of improved assisted reproductive technologies, such as intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), GIFT, and frozen embryo transfer (FET), is fueling the fertility services market expansion.

US Assisted Reproductive Technology Market  is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 2101.5 million

Largest Segment

Artificial Insemination (AI-IUI)

Fastest Growth

Artificial Insemination (AI-IUI)

Growth Rate

19.3% CAGR

Global Assisted Reproductive Technology Market ($ Mn)
Country Share for Europe Region (%)
Country Share for North America Region (%)
Global Assisted Reproductive Technology Market By Technique ($ Mn)
Global Assisted Reproductive Technology Market By Technique (%)

To get more reports on the above market click here to Buy The Report

Global Assisted Reproductive Technology Market Segmental Analysis

The global Assisted reproductive technology market is segmented based on technique, procedure, end user, and region. Based on technique, the Assisted reproductive technology market is segmented into In Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), Others. Based on procedure, the Assisted reproductive technology market is segmented into Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor. Based on end user, the Assisted reproductive technology market is segmented into Hospitals, Fertility Clinics. Based on region, the Assisted reproductive technology market is categorized into North America, Europe, Asia-Pacific, and MEA.

Assisted Reproductive Technology Market Analysis by technique

In 2021, the In Vitro Fertilization Segment dominated the global assisted reproductive technology market and is likely to maintain its dominance throughout the forecast period due to its high procedural success rate and constant innovations that meet patient demand. Previously, sperms were injected to increase the success rate of IVF. However, a time lapse imaging device is being employed to capture an image of egg division. As a result, the introduction of such improved technologies in IVF treatment is one of the assisted reproductive technology industry trends expected to drive the use of fertility services over the forecast period. Frozen embryo transfer (FET), on the other hand, accounted for the second largest assisted reproductive technology market share, owing to the increasing prevalence of infertility worldwide and need for high success rates. This treatment allows the patient to try again after an unsuccessful fresh IVF cycle and is relatively inexpensive. It also avoids a few steps of fresh IVF, resulting in speedier results for patients.

Global Assisted Reproductive Technology Market By Technique, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Assisted Reproductive Technology Market Regional Insights

Europe dominated the market in 2021, accounting for more than 37.20% of total revenue. The large percentage can be linked to an increase in the rate of infertility, improved awareness about fertility treatments, technical developments, and supportive government activities. According to the European Society of Human Reproduction and Embryology, roughly 25 million people in the European Union suffer from infertility, which is the highest rate in the world. During the predicted period, North America is expected to increase significantly. The beneficial outcomes obtained by patients undergoing treatment are linked to the growth.

Global Assisted Reproductive Technology Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Assisted Reproductive Technology Market Dynamics

Assisted Reproductive Technology Market Driver

  • Rising prevalence of infertility is accelerating market growth

The rising frequency of infertility, particularly in China, the United States, the United Kingdom, and India, is likely to drive up demand for ART. According to the National Survey of Family Growth (NSFG), approximately 6.7% of women aged 15 to 44 years in the United States were infertile in 2018. Furthermore, the male population has a greater frequency of infertility internationally, which is expected to accelerate the expansion of the fertility services market. According to data published in the Oxford Journals, one in every ten men in the United Kingdom aged 16 to 74 years has suffered infertility. Sedentary lifestyles, growing stress levels, and obesity among the general population are some of the key factors contributing to the rising prevalence of infertility. As a result, it is likely to drive global demand for ART technology. In addition, several governments and non-profit organizations in developed and developing nations are actively interested in assisting the general people with the goal of providing fertility treatments at low cost. As a result, such measures are expected to promote the growth of the assisted reproductive technology market throughout the forecast period.

Assisted Reproductive Technology Market Restraint

  • The high cost of assisted reproductive technology may impede the market

The high expense of treatment and the socio-ethical stigma connected with the operations are some of the key challenges restricting the global market acceptance of these technologies. According to the World Health Organization (WHO), most women in developing nations cannot afford infertility treatment because to the exorbitant cost.

Request Free Customization of this report to help us to meet your business objectives.

Global Assisted Reproductive Technology Market Competitive Landscape

Key players in the global assisted reproductive technology market are implementing a variety of strategies such as such as product launches, investment in R&D, and the expansion of product portfolios in order to increase their market presence. For instance, in January 2021, CooperSurgical acquired Embryo Options a significant leader in cryo-storage software systems for reproductive clinics. Patients will benefit from the Embryo Options platform's online tools, which will provide information regarding stored specimens for future ART treatment cycles. Hamilton Throne Ltd., a global provider of ART research, for example, acquired IVFTECH ApS (IVFtech) and its subsidiary firm, K4 Technology ApS, in July 2021. With the assistance of its affiliated company, K4, IVFtech is committed to supplying laminar flow workstations and large-capacity incubators for ART. The deal was valued $8 million.

Assisted Reproductive Technology Market Top Players Company Profiles

  • CooperSurgical, Inc. (a subsidiary of The Cooper Companies Inc.)
  • Vitrolife AB
  • Ferring Pharmaceuticals Inc.
  • Cook Medical LLC
  • Irvine Scientific Sales Company Inc. (a subsidiary of Fujifilm Holdings Corporation)
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (through its subsidiary, Merck Serono S.A.)
  • Genea Limited
  • Boston IVF
  • OvaScience Inc. (a subsidiary of Millendo Therapeutics Inc.)
  • IGENOMIX
  • Progyny Inc.
  • Bloom IVF Group
  • IVI-RMA Global
  • CryoChoice LLC
  • Cryos International – USA
  • Cryopoint LLC
  • Reproductive Medicine Associates of New Jersey
  • CARE Fertility Group
  • The Fertility Partnership

Assisted Reproductive Technology Market Recent Development

  • In June 2022, Inception Fertility expanded its ecosystem with the launch of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides a one-of-a-kind experience for fertility doctors and patients. It includes assisted reproductive techniques (ART).
  • In March 2022, CK Birla Healthcare launched its flagship fertility clinic, Birla Fertility in New Delhi with Assisted Reproductive Technology.

Global Assisted Reproductive Technology Key Market Trends

  • The increased acceptance of ART in society as a result of the adoption of more advanced technologies such as Endometrial Receptivity Analysis Testing (ERA), Pre-implantation Genetic Testing (PGT), Magnetic Activated Cell Sorting (MACS), and time-lapse imaging of embryos is expected to drive demand for assisted reproductive technology procedures. According to the CDC's 2019 Reproductive Clinic Success Rates Report, roughly 330,773 assisted reproductive technology operations were performed at 448 fertility clinics in the United States, accounting for 77,998 live births and 83,946 live-born infants. Furthermore, increased awareness regarding the causes and treatment of infertility is projected to move the market forward.

Global Assisted Reproductive Technology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our business information services team that collects, collates, co-relates, and analyses the data collected by means of primary exploratory research backed by the robust secondary desk research.

According to our analysis, Post-pandemic, technological improvement and telemedicine usage in the field of assisted reproductive technology are predicted to drive industry growth. Telehealth use in assisted reproductive technology therapies is still in its early stages. Nonetheless, it has huge future potential due to benefits such as remote monitoring and continuous administration.

Report Metric Details
Market size value in 2023 USD 2101.5 million
Market size value in 2031 USD 12272.5 million
Growth Rate 19.3%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Technique
    • In Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), Others
  • Procedure
    • Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor
  • End User
    • Hospitals, Fertility Clinics
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • CooperSurgical, Inc. (a subsidiary of The Cooper Companies Inc.)
  • Vitrolife AB
  • Ferring Pharmaceuticals Inc.
  • Cook Medical LLC
  • Irvine Scientific Sales Company Inc. (a subsidiary of Fujifilm Holdings Corporation)
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (through its subsidiary, Merck Serono S.A.)
  • Genea Limited
  • Boston IVF
  • OvaScience Inc. (a subsidiary of Millendo Therapeutics Inc.)
  • IGENOMIX
  • Progyny Inc.
  • Bloom IVF Group
  • IVI-RMA Global
  • CryoChoice LLC
  • Cryos International – USA
  • Cryopoint LLC
  • Reproductive Medicine Associates of New Jersey
  • CARE Fertility Group
  • The Fertility Partnership
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Assisted Reproductive Technology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Assisted Reproductive Technology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Assisted Reproductive Technology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Assisted Reproductive Technology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Assisted Reproductive Technology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Assisted Reproductive Technology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Assisted Reproductive Technology Market size was valued at USD 2101.5 million in 2019 and is poised to grow from USD 2507.09 million in 2023 to USD 12272.5 million by 2031, growing at a CAGR of 19.3% in the forecast period (2024-2031).

Key players in the global assisted reproductive technology market are implementing a variety of strategies such as such as product launches, investment in R&D, and the expansion of product portfolios in order to increase their market presence. For instance, in January 2021, CooperSurgical acquired Embryo Options a significant leader in cryo-storage software systems for reproductive clinics. Patients will benefit from the Embryo Options platform's online tools, which will provide information regarding stored specimens for future ART treatment cycles. Hamilton Throne Ltd., a global provider of ART research, for example, acquired IVFTECH ApS (IVFtech) and its subsidiary firm, K4 Technology ApS, in July 2021. With the assistance of its affiliated company, K4, IVFtech is committed to supplying laminar flow workstations and large-capacity incubators for ART. The deal was valued $8 million. 'CooperSurgical, Inc. (a subsidiary of The Cooper Companies Inc.)', 'Vitrolife AB', 'Ferring Pharmaceuticals Inc.', 'Cook Medical LLC', 'Irvine Scientific Sales Company Inc. (a subsidiary of Fujifilm Holdings Corporation)', 'Thermo Fisher Scientific Inc.', 'Merck KGaA (through its subsidiary, Merck Serono S.A.)', 'Genea Limited', 'Boston IVF', 'OvaScience Inc. (a subsidiary of Millendo Therapeutics Inc.)', 'IGENOMIX', 'Progyny Inc.', 'Bloom IVF Group', 'IVI-RMA Global', 'CryoChoice LLC', 'Cryos International – USA', 'Cryopoint LLC', 'Reproductive Medicine Associates of New Jersey', 'CARE Fertility Group', 'The Fertility Partnership'

Rising prevalence of infertility is accelerating market growth

The increased acceptance of ART in society as a result of the adoption of more advanced technologies such as Endometrial Receptivity Analysis Testing (ERA), Pre-implantation Genetic Testing (PGT), Magnetic Activated Cell Sorting (MACS), and time-lapse imaging of embryos is expected to drive demand for assisted reproductive technology procedures. According to the CDC's 2019 Reproductive Clinic Success Rates Report, roughly 330,773 assisted reproductive technology operations were performed at 448 fertility clinics in the United States, accounting for 77,998 live births and 83,946 live-born infants. Furthermore, increased awareness regarding the causes and treatment of infertility is projected to move the market forward.

Europe dominated the market in 2021, accounting for more than 37.20% of total revenue. The large percentage can be linked to an increase in the rate of infertility, improved awareness about fertility treatments, technical developments, and supportive government activities. According to the European Society of Human Reproduction and Embryology, roughly 25 million people in the European Union suffer from infertility, which is the highest rate in the world. During the predicted period, North America is expected to increase significantly. The beneficial outcomes obtained by patients undergoing treatment are linked to the growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Assisted reproductive technology Market

Product ID: SQMIG35G2228

$5,300
BUY NOW GET FREE SAMPLE